SOUTH JORDAN, Utah, Feb. 21, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that it has entered into an exclusive distribution agreement with Milamy Partners LLC for the KanguruWeb(tm) Abdominal Retraction System.
Effective March 1, Merit Medical will have exclusive worldwide marketing, distribution and sales rights to the KanguruWeb(tm) system in interventional and diagnostic cardiology and radiology labs and imaging centers.
"This product provides health care workers with a solution in working with patients with specialized needs, while reducing preparation time and maintaining the dignity of the patient," said Fred P. Lampropoulos, Merit's Chairman and Chief Executive Officer.
The Company will discuss market opportunities for the KanguruWeb(tm) during its upcoming conference call on Wednesday, February 28, at 3:00 p.m. Mountain Time. The telephone numbers to call are (domestic) 800-240-2430; and (international) 303-262-2137. A live webcast will also be available at www.merit.com and www.fulldisclosure.com.
About Merit
Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology and radiology. Merit serves client hospitals worldwide with a domestic and international sales force totaling approximately 85 individuals. Merit employs approximately 1,750 people worldwide, with facilities in Salt Lake City and South Jordan, Utah; Santa Clara, California; Angleton, Texas; Richmond, Virginia; Maastricht and Venlo, The Netherlands; and Galway, Ireland.
The Merit Medical Systems, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3282
Statements contained in this release, which are not purely historical, are forward-looking statements within the meaning of the Private Securities Litigation Act of 1995 and are subject to risks and uncertainties such as those described in Merit's Annual Report on Form 10-K for the year ended December 31, 2005. Such risks and uncertainties include market acceptance of new products, introduction of products in a timely fashion, product recalls, delays in obtaining regulatory approvals, or the failure to maintain such approvals, cost increases, fluctuations in and obsolescence of inventory, price and product competition, availability of labor and materials, development of new products and technology that could render Merit's products obsolete, product liability claims, modification or limitation of governmental or private insurance reimbursement, infringement of Merit's technology or the assertion that Merit's technology infringes the rights of other parties, foreign currency fluctuations, challenges associated with the Company's growth strategy, changes in health care markets related to health care reform initiatives, litigation and other factors referred to in the Company's 10-K and other reports filed with the Securities and Exchange Commission. All subsequent forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these cautionary statements. Actual results may differ materially from anticipated results. Financial estimates are subject to change and are not intended to be relied upon as predictions of future operating results, and Merit assumes no obligation to update or disclose revisions to those estimates.